Core Scientific (CORZ) has drawn fresh attention after securing $600 million in committed senior secured credit facilities, a funding move that reshapes its access to capital for bitcoin mining and AI hosting expansion.

The new credit facilities arrive after a sharp pullback, with Core Scientific’s share price down 38.51% over the past 90 days and 8.89% over the past month, even though the year to date share price return is positive at 3.25% and the 1 year total shareholder return sits at 15.05%. This suggests that recent selling pressure has started to outweigh the prior upswing.

Spot opportunities riding the same bitcoin mining and AI infrastructure theme as Core Scientific by scanning our hand picked 56 AI infrastructure stocks.

Core Scientific now has fresh credit lines, released cash, and a sharp share price reset working in opposite directions. The business appears larger and better funded. The open question is whether the stock already reflects that.

Most Popular Narrative: 56% Undervalued

Against Core Scientific's last close of $16.51, the most followed narrative points to a fair value of $37.13, which implies a large valuation gap that hinges on long dated AI and high performance compute contracts.

The analysts have a consensus price target of $37.12 for Core Scientific based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $55.0, and the most bearish reporting a price target of just $28.0.

Want to understand why this narrative assigns such a high fair value to Core Scientific? The story leans heavily on aggressive revenue expansion, sharply higher margins, and a future earnings profile that assumes a premium valuation multiple. Curious which of those levers does most of the lifting in the model.

Result: Fair Value of $37.13 (UNDERVALUED)

However, Core Scientific’s reliance on large, long dated AI and high performance compute contracts and the company’s recent net losses could still derail this optimistic narrative.

Another View: What Core Scientific’s Sales Multiple Is Telling You

The analyst narrative frames Core Scientific as undervalued relative to a $37.13 fair value. Yet the current P/S ratio of 12x is very high compared with a fair ratio of 6.9x and peer and industry averages of 2.4x and 4x. That gap points to meaningful valuation risk if sentiment cools.

Next Steps

With Core Scientific attracting strong views on both risks and rewards, it may be useful to move quickly and review the available information for yourself. To see both sides in one place, review the 1 key reward and 3 important warning signs.

Looking for more investment ideas beyond Core Scientific?

If you stop with Core Scientific, you risk missing other compelling setups. Use the Simply Wall Street Screener to quickly surface stocks that better match your goals.

• Target potential mispricing by reviewing the 45 high quality undervalued stocks that combine solid fundamentals with appealing valuations.
• Build a sturdier core to your portfolio by scanning the list of solid balance sheet and fundamentals (51 results) that can better handle tougher conditions.
• Strengthen your income stream by reviewing the 12 dividend fortresses that offer higher yields with a focus on sustainability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.